SEFRIA Methamphetamine Oral Fluid Enzyme Immunoassay— 510(k) K203647

Substantially Equivalent

Immunalysis Corporation

FDA 510(k) clearance K203647 for SEFRIA Methamphetamine Oral Fluid Enzyme Immunoassay, Substantially Equivalent on 2021-12-22. Applicant: Immunalysis Corporation.

Clearance details

Applicant
Immunalysis Corporation
Product code
Code LAF
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Pomona, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.